The high-resolution crystal structure of human LCAT1

Journal of Lipid Research

Volumn 56, Issue 9, 2015, Pages 1711-1719

  Piper, Derek E ^a   Romanow, William G ^a   Gunawardane, Ruwanthi N ^b   Fordstrom, Preston ^a   Masterman, Stephanie ^a   Pan, Oscar ^a   Thibault, Stephen T ^a   Zhang, Richard ^a   Meininger, David ^b   Schwarz, Margrit ^a   Wang, Zhulun ^a   King, Chadwick ^a   Zhou, Mingyue ^a   Walker, Nigel P C ^a  

^a AMGEN INC   (United States)

^b AMGEN INC   (United States)

Author keywords

Antibodies; Cholesterol; High density lipoprotein; Lecithin:cholesterol acyltransferase; X ray crystallography

Indexed keywords

PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; CHOLESTEROL; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CATALYSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; SEQUENCE HOMOLOGY; SIZE EXCLUSION CHROMATOGRAPHY; THERMOSTABILITY; CHEMISTRY; GENETICS; METABOLISM; MUTATION; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY;

CHOLESTEROL; CRYSTALLOGRAPHY, X-RAY; HUMANS; MUTATION; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PROTEIN BINDING; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

EID: 84940887817     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M059873     Document Type: Article

References (41)

1. Jonas, A. 2000. Lecithin cholesterol acyltransferase. Biochim. Biophys. Acta . 1529: 245-256.
2. Ohashi, R., H. Mu, X. Wang, Q. Yao, and C. Chen. 2005. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM. 98: 845-856.
3. Kuivenhoven, J. A., H. Pritchard, J. Hill, J. Frohlich, G. Assmann, and J. Kastelein. 1997. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res. 38: 191-205.
4. Kunnen, S., and M. Van Eck. 2012. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis? J. Lipid Res. 53: 1783-1799.
5. Glomset, J. A. 1962. The mechanism of the plasma cholesterol esterification reaction: plasma fatty acid transferase. Biochim. Biophys. Acta. 65: 128-135.
6. Glomset, J. A. 1968. The plasma lecithins:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
7. Qu, S. J., H. Z. Fan, F. Blanco-Vaca, and H. J. Pownall. 1993. Effects of site-directed mutagenesis on the N-glycosylation sites of human lecithin:cholesterol acyltransferase. Biochemistry. 32: 8732-8736.
8. O., K., J. S. Hill, X. Wang, R. McLeod, and P. H. Pritchard. 1993. Lecithin:cholesterol acyltransferase: role of N-linked glycosylation in enzyme function. Biochem. J. 294: 879-884.
9. Yang, C. Y., D. Manoogian, Q. Pao, F. S. Lee, R. D. Knapp, A. M. Gotto, Jr ., and H. J. Pownall. 1987. Lecithin:cholesterol acyltransferase. Functional regions and a structural model of the enzyme. J. Biol. Chem. 262: 3086-3091.
10. Francone, O. L., and C. J. Fielding. 1991. Structure-function relationships in human lecithin:cholesterol acyltransferase. Sitedirected mutagenesis at serine residues 181 and 216. Biochemistry. 30: 10074-10077.
11. Peelman, F., N. Vinaimont, A. Verhee, B., Vanloo, J. L. Verschelde, C. Labeur, S. Seguret-Mace, N. Duverger, G. Hutchinson, J. Vandekerckhove, et al. 1998. A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling . Protein Sci. 7: 587-599.
12. Durocher, Y., S. Perret, and A. Kamen. 2002. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30: E9.
13. Battye, T. G., L. Kontogiannis, O. Johnson, H. R. Powell, and A. G. Leslie . 2011. iMOSFLM: a new graphical interface for diffractionimage processing with MOSFLM. Acta Crystallogr. D Biol. Crystallogr. 67: 271-281.
14. Evans, P. 2006. Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62: 72-82.
15. Winn, M. D., C. C. Ballard, K. D. Cowtan, E. J. Dodson, P. Emsley, P. R. Evans, R. M. Keegan, E. B. Krissinel, A. G. Leslie, A. McCoy, et al. 2011. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67: 235-242.
16. McCoy, A. J., R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, and R. J. Read. 2007. Phaser crystallographic software. J. Appl. Crystallogr. 40: 658-674.
17. Cowtan, K. D. 1994. dm: an automated procedure for phase improvement by density modification. Joint CCP4 and ESF-EACBM Newsl. Protein Crystallogr. 31: 34-38.
18. Brünger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, et al. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54: 905-921.
19. Adams, P. D., P. V. Afonine, G. Bunkoczi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L. W. Hung, G. J. Kapral, R. W. Grosse- Kunstleve, et al. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66: 213-221.
20. Emsley, P., B. Lohkamp, W. G. Scott, and K. Cowtan. 2010. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66: 486-501.
21. Chen, V. B., W. B. Arendall III, J. J. Headd, D. A. Keedy, R. M. Immormino, G. J. Kapral, L. W. Murray, J. S. Richardson, and D. C. Richardson. 2010. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66: 12-21.
22. DeLano, W. L. 2002 . The PyMOL Molecular Graphics System. DeLano Scientific, Palo Alto, CA.
23. Lima, V. L. M., L. C. B. B. Coelho, J. F. Kennedy, J. S. Owen, and P. J. Dolphin. 2004. Lecithin-cholesterol acyltransferase (LCAT) as a plasma glycoprotein: an overview. Carbohydr. Polym. 55: 179-191.
24. Chang, V. T., M. Crispin, A. R. Aricescu, D. J. Harvey, J. E. Nettleship, J. A. Fennelly, C. Yu, K. S. Boles, E. J. Evans, D. I. Stuart, et al. 2007. Glycoprotein structural genomics: solving the glycosylation problem. Structure. 15: 267-273.
25. Nardini, M., and B. W. Dijkstra. 1999. Alpha/beta hydrolase fold enzymes: the family keeps growing. Curr. Opin. Struct. Biol. 9: 732-737.
26. Jaeger, K. E., B. W. Dijkstra, and M. T. Reetz. 1999. Bacterial biocatalysts: molecular biology, three-dimensional structures, and biotechnological applications of lipases. Annu. Rev. Microbiol. 53: 315-351.
27. Krissinel, E., and K. Henrick. 2004. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60: 2256-2268.
28. Holleboom, A. G., J. A. Kuivenhoven, F. Peelman, A. W. Schimmel, J. Peter, J. C. Defesche, J. J. Kastelein, G. K. Hovingh, E. S. Stroes, and M. M. Motazacker. 2011. High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations. Hum. Mutat. 32: 1290-1298.
29. Adimoolam, S., and A. Jonas. 1997. Identification of a domain of lecithin-cholesterol acyltransferase that is involved in interfacial recognition. Biochem. Biophys. Res. Commun. 232: 783-787.
30. Jin, L., J. J. Shieh, E. Grabbe, S. Adimoolam, D. Durbin, and A. Jonas. 1999. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins. Biochemistry. 38: 15659-15665.
31. Peelman, F., B. Vanloo, O. Perez-Mendez, A. Decout, J. L. Verschelde, C. Labeur, N. Vinaimont, A. Verhee, N. Duverger, R. Brasseur, et al. 1999. Characterization of functional residues in the interfacial recognition domain of lecithin cholesterol acyltransferase (LCAT). Protein Eng. 12: 71-78.
32. Schrag, J. D., Y. Li, M. Cygler, D. Lang, T. Burgdorf, H. J. Hecht, R. Schmid, D. Schomburg, T. J. Rydel, J. D. Oliver, et al. 1997. The open conformation of a Pseudomonas lipase. Structure. 5: 187-202.
33. Noble, M. E., A. Cleasby, L. N. Johnson, M. R. Egmond, and L. G. Frenken. 1993. The crystal structure of triacylglycerol lipase from Pseudomonas glumae reveals a partially redundant catalytic aspartate. FEBS Lett. 331: 123-128.
34. Roussel, A., S. Canaan, M. P. Egloff, M. Riviere, L. Dupuis, R. Verger, and C. Cambillau. 1999. Crystal structure of human gastric lipase and model of lysosomal acid lipase, two lipolytic enzymes of medical interest. J. Biol. Chem. 274: 16995-17002.
35. Labar, G., C. Bauvois, F. Borel, J. L. Ferrer, J. Wouters, and D. M. Lambert . 2010 . Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling. ChemBioChem. 11: 218-227.
36. Calabresi, L., L. Pisciotta, A. Costantin, I. Frigerio, I. Eberini, P. Alessandrini, M. Arca, G. B. Bon, G. Boscutti, G. Busnach, et al. 2005. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler. Thromb. Vasc. Biol. 25: 1972-1978.
37. Holleboom, A. G., J. A. Kuivenhoven, C. C. van Olden, J. Peter, A. W. Schimmel, J. H. Levels, R. M. Valentijn, P. Vos, J. C. Defesche, J. J. Kastelein, et al. 2011. Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase. Atherosclerosis . 216: 161-165.
38. Peelman, F., J. L. Verschelde, B. Vanloo, C. Ampe, C. Labeur, J. Tavernier, J. Vandekerckhove, and M. Rosseneu. 1999. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity. J. Lipid Res. 40: 59-69.
39. Hörl, G., P. M. Kroisel, E. Wagner, B. Tiran, E. Petek, and E. Steyrer. 2006. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease. Atherosclerosis. 187: 101-109.
40. Qu, S. J., H. Z. Fan, F. Blanco-Vaca, and H. J. Pownall. 1995. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase. J. Lipid Res. 36: 967-974.
41. Glukhova,A. V.Hinkovska-Galcheva R.Kelly A.Abe J. A.Shayman J. J.Tesmer2015Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase.Nat. Commun.66250